1.
Gülbay B, Acıcan T. Obstrüktif uyku apne sendromunda medikaltedavi. Turkiye Klinikleri Journal of Pulmonary Medicine SpecialTopics 2008; 1: 120.
2.
Berry RB, Gamaldo CE, Harding SM, et al. AASM ScoringManual Version 2.2 Updates: New Chapters for Scoring InfantSleep Staging and Home Sleep Apnea Testing. J Clin Sleep Med2015; 11: 1253-4.
3.
Lee KA. An overview of sleep and common sleep problems.ANNA J 1997; 24: 614-23, 77; quiz 24-5.
4.
Goh DY, Galster P, Marcus CL. Sleep architecture and respiratorydisturbances in children with obstructive sleep apnea. Am JRespir Crit Care Med 2000; 162: 682-6.
5.
Iber C, Ancoli-Israel S, Chesson A, Quan SF for The AmericanAcademy of Sleep Medicine The AASM manual for the scoringof sleep and associated events: rules, terminology and technicalspecifications 2007 Westchester.
6.
Butkov Nic. Atlas of clinical polysomnography Synapse Media2010.
7.
Kayaalp O. Akılcı Tedavi Yönünde Tıbbi Farmakoloji 12. Baskı Ankara: Pelikan Yayınevleri 2009: 770-95.
8.
Aron H. Depression: the benefits of early and appropriatetreatment. Am J Managed Care 2007: S92.
9.
Saygın M, Özgüner M. Uykunun mikro yapısı ve mimarisi. UykuBülteni 2020; 1: 19-29.
10.
Pressman M. Evaluating sleep stages. In: Primer of polysomnograminterpretation 1st edition January 14, 2002.
11.
Karadağ M. Polisomnografi. İçinde: Kaya A, Karadag M, Özlü T.Göğüs Hastalıkları Propedötik İstanbul: Aves. 2004: 255-63.
12.
Morin CM. Benca RM. Nature and treatment of insomnia, in SleepDisorders Medicine Basic Science, Technical Considerations andClinical Aspects, 2008 3rd ed. edited by S. Chokroverty, Elsevier/Butterworth, Philadelphia.
13.
Thomas R, Timothy R. Insomnia: Pathophysiology andimplications for treatment, Theoretıcal revıew. Ron Pies SleepMedicine Reviews 2007; 11: 71-9.
14.
Banks S, Dinges DF. Behavioral and physiological consequencesof sleep restriction. J Clin Sleep Med 2007; 3: 519-28.
15.
Hutka P, Krivosova M, Muchova Z, et al. Association of SleepArchitecture and Physiology with Depressive Disorder andAntidepressants Treatment. Int J Mol Sci 2021; 22: 1333.
16.
Monaca C, Boutrel B, Hen R, Hamon M, Adrien J. 5-HT 1A/1Breceptor-mediated effects of the selective serotonin reuptakeinhibitor, citalopram, on sleep: Studies in 5-HT 1A and 5-HT 1Bknockout mice. Neuropsychopharmacology 2003; 28: 850-6.
17.
Sallanon M, Buda C, Janin M, et al. Implication of serotonin insleep mechanisms: induction, facilitation? Neurotransmitters andNeuromodulators. New York: Raven Press 1985 p. 136.
18.
Mayers AG, Baldwin DS. Antidepressants and their effect onsleep. Hum Psychopharmacol 2005;20: 533-59.
19.
Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administeredwith fluoxetine in patients with insomnia coexisting with majordepressive disorder. Biol Psychiatry 2006; 59: 1052-60.
20.
Katerndahl D, Ferrer R. Knowledge about recommended treatmentand management of major depressive disorder, panic disorder,and generalized anxiety disorder among family physicians. PrimCare Companion J Clin Psychiatry 2004; 6, 147-51.
21.
Örsel, S. Depresyonda Tedavi: Genel İlkeler ve KullanılanAntidepresan İlaçlar. Klinik Psikiyatri 2004; 4: 17-24.
22.
Köktürk, Oğuz. Uyku kayıtlarının skorlanması. Türk SolunumAraştırma Derneği Solunum 2013; 15: 14-29.